VanEck Semiconductor ETF vs Teladoc Health Inc — how do they compare? VanEck Semiconductor ETF trades at $602.27 (market cap $73.92B), while Teladoc Health Inc trades at $5.69 (market cap $1.01B). The key difference: VanEck Semiconductor ETF is far larger — about 73.2× Teladoc Health Inc's market cap, and VanEck Semiconductor ETF is trading nearer its 52-week high, Teladoc Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Semiconductor ETF for 101 Days and Teladoc Health Inc for 39 Days on average.
| SMH | TDOC | |
|---|---|---|
Market Cap | $73.92B | $1.01B |
Volume | 11,050,892 | 4,668,477 |
52-Week High | $668.91 | $9.72 |
52-Week Low | $325.10 | $4.47 |
Typical Hold Time | 101 Days | 39 Days |
Sector | — | Health |
Enterprise Value | — | $1.27B |
Signals from Pluang's Aura AI — not financial advice
SMH (VanEck Semiconductor ETF) trades at $606.11, down 3.03% on the day, but maintains a strong bullish technical outlook with moving averages signaling continued strength. The ETF has delivered exceptional 69% returns year-to-date through September 30, 2026, significantly outperforming major semiconductor holdings like Nvidia. Recent sector momentum is supported by positive industry developments including AMD's $8.2 billion acquisition of World Labs and Bank of America's projection that the global chip market will nearly double by 2030.
The semiconductor sector's structural growth drivers, particularly in AI hardware, support continued ETF appreciation, though concentration risk in top holdings and elevated RSI levels near 76 suggest potential near-term consolidation. Investors benefit from diversified exposure to the physical AI infrastructure boom, but should monitor valuation metrics as the sector trades at elevated levels following substantial gains.
Teladoc Health (TDOC) trades at $5.67, showing modest daily gains but remains near multi-year lows with a bearish technical outlook. The company maintains strong revenue around $2.5B annually but continues to report net losses, with a -7.13% net margin in 2026. Recent management changes include the appointment of a new CFO, while analyst sentiment remains cautious despite a consensus price target of $8.83 representing 56% upside potential.
TDOC presents a high-risk opportunity with significant upside potential if the company can achieve profitability turnaround. The stock trades at discounted valuations (P/S 0.4x, P/B 0.77x) but faces execution risks from ongoing losses, BetterHelp segment challenges, and potential legal investigations. Free cash flow generation and integrated care growth provide stabilization, though sustained profitability remains the key catalyst needed for sustained recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →